Tracy Irura, Chief Clinician at Integrated Cancer Research Foundation of Kenya, Adjunct Lecturer at Jomo Kenyatta University of Agriculture and Technology (JKUAT), shared on LinkedIn:
“Cervical Cancer Elimination Needs to Be Built on African Evidence
As we mark Cervical Cancer Elimination Day this week, I am proud to share a research paper we have conducted in Kenya:
Clinicopathological Characteristics of Women with Cervical Cancer at Moi Teaching and Referral Hospital, Kenya.
Published in the Journal of Cancer Therapy (2026), our study reviewed 290 patient records and highlights important realities of cervical cancer in our setting.
Key findings include:
- 90.2% of patients came from rural areas.
- 51.4% presented with advanced-stage disease (FIGO III–IV).
- 50.2% were uninsured.
- Previous cervical cancer screening was documented in only 1% of patient records.
These findings reinforce the urgent need to strengthen HPV vaccination, screening, early diagnosis and access to timely treatment.
The WHO 90–70–90 targets are achievable, but we must translate these ambitions into action.
Africa needs more locally generated evidence to inform our cancer policies, interventions and priorities. Grateful to my co-authors, Priscah Chelangat and George Muthui, for this important contribution to cancer research in Kenya.
No woman should die from a preventable cancer.
Together, let us turn cervical cancer elimination from a global ambition into an African reality.”
Title: Clinicopathological Characteristics of Women with Cervical Cancer at Chandaria Cancer Centre, Moi Teaching and Referral Hospital, Kenya
Authors: Priscah Chelangat, Tracy Irura, George Muthui
Read the Full Article on Journal of Cancer Therapy
You can also read: A New Era in Cervical Cancer Prevention in Algeria: Integration of HPV Vaccination into the National Immunization Program
